97 related articles for article (PubMed ID: 11447030)
1. Activation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation.
Watts JA; Grattan RM; Whitlow BS; Kline JA
Am J Physiol Gastrointest Liver Physiol; 2001 Aug; 281(2):G498-506. PubMed ID: 11447030
[TBL] [Abstract][Full Text] [Related]
2. Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase.
Liaudet L; Soriano FG; Szabó E; Virág L; Mabley JG; Salzman AL; Szabo C
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10203-8. PubMed ID: 10954738
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock.
McDonald MC; Filipe HM; Thiemermann C
Br J Pharmacol; 1999 Nov; 128(6):1339-45. PubMed ID: 10578150
[TBL] [Abstract][Full Text] [Related]
4. Increased poly(ADP-ribose) polymerase activity during porcine hemorrhagic shock is transient and predictive of mortality.
Skarda DE; Putt KS; Hergenrother PJ; Mulier KE; Beilman GJ
Resuscitation; 2007 Oct; 75(1):135-44. PubMed ID: 17467870
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock.
McDonald MC; Mota-Filipe H; Wright JA; Abdelrahman M; Threadgill MD; Thompson AS; Thiemermann C
Br J Pharmacol; 2000 Jun; 130(4):843-50. PubMed ID: 10864891
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats.
Roesner JP; Vagts DA; Iber T; Eipel C; Vollmar B; Nöldge-Schomburg GF
Intensive Care Med; 2006 Oct; 32(10):1649-57. PubMed ID: 16927075
[TBL] [Abstract][Full Text] [Related]
7. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
[TBL] [Abstract][Full Text] [Related]
9. Caspase inhibition does not protect against liver damage in hemorrhagic shock.
Mauriz JL; González P; Jorquera F; Olcoz JL; González-Gallego J
Shock; 2003 Jan; 19(1):33-7. PubMed ID: 12558141
[TBL] [Abstract][Full Text] [Related]
10. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
11. Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats.
Lescot T; Fulla-Oller L; Palmier B; Po C; Beziaud T; Puybasset L; Plotkine M; Gillet B; Meric P; Marchand-Leroux C
J Neurotrauma; 2010 Jun; 27(6):1069-79. PubMed ID: 20380552
[TBL] [Abstract][Full Text] [Related]
12. Hepatic apoptosis after hemorrhagic shock in rats can be reduced through modifications of conventional Ringer's solution.
Jaskille A; Koustova E; Rhee P; Britten-Webb J; Chen H; Valeri CR; Kirkpatrick JR; Alam HB
J Am Coll Surg; 2006 Jan; 202(1):25-35. PubMed ID: 16377494
[TBL] [Abstract][Full Text] [Related]
13. 3-Aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase, improves hemodynamics and prolongs survival in a porcine model of hemorrhagic shock.
Szabó A; Hake P; Salzman AL; Szabó C
Shock; 1998 Nov; 10(5):347-53. PubMed ID: 9840650
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of poly(ADP-ribose) synthetase improves vascular contractile responses following trauma-hemorrhage and resuscitation.
St John J; Barbee RW; Sonin N; Clemens MG; Watts JA
Shock; 1999 Sep; 12(3):188-95. PubMed ID: 10485596
[TBL] [Abstract][Full Text] [Related]
15. Poly (ADP-ribose) polymerase activation and circulatory shock.
Szabó C
Novartis Found Symp; 2007; 280():92-103; discussion 103-7, 160-4. PubMed ID: 17380790
[TBL] [Abstract][Full Text] [Related]
16. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan J; O'Connor M; Hake PW; Zingarelli B
Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
Cover C; Fickert P; Knight TR; Fuchsbichler A; Farhood A; Trauner M; Jaeschke H
Toxicol Sci; 2005 Mar; 84(1):201-8. PubMed ID: 15601672
[TBL] [Abstract][Full Text] [Related]
19. PISA, a novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ.
Lubbers LS; Rowe BA; Hodge LM; Browne SE; Gundersdorf R; Jones P; Hess FJ; Reynolds IJ
J Pharmacol Toxicol Methods; 2010; 61(3):319-28. PubMed ID: 20132901
[TBL] [Abstract][Full Text] [Related]
20. Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock.
Evgenov OV; Liaudet L
Curr Vasc Pharmacol; 2005 Jul; 3(3):293-9. PubMed ID: 16026325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
